Approval · Notice of Compliance 12655 · 2011
IMITREX DF: Notice of Compliance 12655
Issued September 23, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12655
- Date
- September 23, 2011
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Removal of the 25 mg Strength from the PRoduct monograph
- Therapeutic class
- 5-HT1 Receptor Agonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IMITREX DF | Not yet assigned | — |
Medicinal ingredients
- SUMATRIPTAN SUCCINATE 50 MG per TAB
- SUMATRIPTAN SUCCINATE 100 MG per TAB